ReportsNov 9, 2026 · after close
Fiscal periodNot stated
Market cap$6.57B
Consensus EPS$0.07 · 4 estimates
Year-ago EPS$0.06
Expected change+16.7%
Quarterly markets
What will Hims say during their next earnings call?
Trade- Peptide91%
- FDA88%
- Eucalyptus88%
- Wegovy88%
- Australia87%
- Lab Testing86%
- Longevity86%
- Perimenopause / Menopause86%
- Testosterone80%
- Canada / Canadian78%
- Wearable75%
- Europe69%
Q3 Subscribers
Full year
Subscribers
Other figures HIMS reports
9 more reported metrics with no market on them yetQ4 2024 reported
No market on this figure$168+14.3% QoQ